Elgin Özkan

916 total citations
82 papers, 598 citations indexed

About

Elgin Özkan is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Elgin Özkan has authored 82 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Radiology, Nuclear Medicine and Imaging, 31 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Elgin Özkan's work include Medical Imaging Techniques and Applications (16 papers), Radiomics and Machine Learning in Medical Imaging (16 papers) and Thyroid Cancer Diagnosis and Treatment (15 papers). Elgin Özkan is often cited by papers focused on Medical Imaging Techniques and Applications (16 papers), Radiomics and Machine Learning in Medical Imaging (16 papers) and Thyroid Cancer Diagnosis and Treatment (15 papers). Elgin Özkan collaborates with scholars based in Türkiye, United States and United Kingdom. Elgin Özkan's co-authors include Çiğdem Soydal, Mine Araz, Metin Kır, Gülseren Araş, Erkan İbiş, Ömer Küçük, Sadık Bilgiç, Murat Faik Erdoğan, Çağdaş Kalkan and Ahmet Eroğlu and has published in prestigious journals such as Blood, European Journal of Nuclear Medicine and Molecular Imaging and Digestive Diseases and Sciences.

In The Last Decade

Elgin Özkan

74 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elgin Özkan Türkiye 14 215 209 181 173 120 82 598
Patrizia Pacini Italy 16 112 0.5× 121 0.6× 165 0.9× 187 1.1× 148 1.2× 45 709
Bedii Kanmaz Türkiye 11 171 0.8× 147 0.7× 129 0.7× 148 0.9× 88 0.7× 28 476
Shigeru Kato Japan 18 156 0.7× 56 0.3× 165 0.9× 368 2.1× 30 0.3× 64 831
Takashi Suda Japan 18 346 1.6× 72 0.3× 108 0.6× 386 2.2× 63 0.5× 87 880
Herbert Maier Austria 14 217 1.0× 41 0.2× 105 0.6× 168 1.0× 22 0.2× 42 532
Wolfram Wermke Germany 15 184 0.9× 60 0.3× 322 1.8× 416 2.4× 15 0.1× 50 742
Meiping Shen China 15 97 0.5× 146 0.7× 51 0.3× 139 0.8× 204 1.7× 39 752
Naoko Ose Japan 15 210 1.0× 44 0.2× 171 0.9× 128 0.7× 53 0.4× 90 591
Jörg S. Bleck Germany 9 461 2.1× 142 0.7× 79 0.4× 214 1.2× 17 0.1× 10 721
Suresh Maximin United States 10 92 0.4× 73 0.3× 86 0.5× 146 0.8× 39 0.3× 18 447

Countries citing papers authored by Elgin Özkan

Since Specialization
Citations

This map shows the geographic impact of Elgin Özkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elgin Özkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elgin Özkan more than expected).

Fields of papers citing papers by Elgin Özkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elgin Özkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elgin Özkan. The network helps show where Elgin Özkan may publish in the future.

Co-authorship network of co-authors of Elgin Özkan

This figure shows the co-authorship network connecting the top 25 collaborators of Elgin Özkan. A scholar is included among the top collaborators of Elgin Özkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elgin Özkan. Elgin Özkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özkan, Elgin, et al.. (2025). Prediction of [177Lu]Lu-PSMA-617 treatment response with [68Ga]Ga-PSMA-11 PET-derived variables and correlation of the overall survival with serum PSA and PSMA PET-based response criteria. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 45(2). 500208–500208.
2.
Özkan, Elgin, et al.. (2024). PET/MR Imagıng in Head and Neck Cancers. 10(3). 274–283.
3.
Özkan, Elgin, et al.. (2023). PSMA Targeted Ligands in Imaging and Theranostics for Prostate Cancer. 22(4). 129–137. 1 indexed citations
4.
Araz, Mine, et al.. (2022). Can Radiomics Analyses in <sup>18</sup>F-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?. Molecular Imaging and Radionuclide Therapy. 31(1). 49–56. 8 indexed citations
5.
Soydal, Çiğdem, Mine Araz, Elgin Özkan, et al.. (2022). Elevated Angiogenic Factor Levels After Transarterial Radioembolization for Colorectal Cancer Liver Metastases May Predict a Poor Prognosis. Molecular Imaging and Radionuclide Therapy. 31(2). 114–122. 2 indexed citations
6.
Araz, Mine, et al.. (2021). Myocardial perfusion SPECT findings in postCOVID period. European Journal of Nuclear Medicine and Molecular Imaging. 49(3). 889–894. 6 indexed citations
7.
Araz, Mine, et al.. (2021). Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 37(1). 56–62. 1 indexed citations
9.
Soydal, Çiğdem, et al.. (2019). Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma. Molecular Imaging and Radionuclide Therapy. 28(2). 69–75. 2 indexed citations
10.
Araz, Mine, et al.. (2019). An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 47(1). 218–219. 1 indexed citations
11.
Seval, Güldane Cengiz, Elgin Özkan, & Meral Beksac. (2019). PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma. PET Clinics. 14(3). 369–381. 5 indexed citations
12.
Araz, Mine, Çiğdem Soydal, Elgin Özkan, et al.. (2018). The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism. Nuclear Medicine Communications. 39(11). 989–994. 34 indexed citations
14.
Soydal, Çiğdem, et al.. (2013). Evaluation of the Response to Selective Internal Radiation Therapy in Patients With Hepatocellular Cancer According to Pretreatment 99mTc-MAA Uptake. Clinical Nuclear Medicine. 38(4). 252–255. 5 indexed citations
17.
Soydal, Çiğdem, et al.. (2011). Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors. World Journal of Surgical Oncology. 9(1). 86–86. 31 indexed citations
18.
Özkan, Elgin, et al.. (2011). Ocular Involvement in Mantle Cell Lymphoma Detected by F 18 FDG PET/CT. Molecular Imaging and Radionuclide Therapy. 20(1). 36–37. 3 indexed citations
19.
Küçük, Ömer, et al.. (2009). Evaluation of Extrapulmonary Ga-67 Uptake in Sarcoidosis: A Retrospective Analysis. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(2). 375–380. 1 indexed citations
20.
Özkan, Elgin, et al.. (2003). Visualization of Collaterals in Budd-Chiari Syndrome with Tc-99m MDP Bone Scintigraphy and Tc-99m HMPAO-Labeled Leukocyte Scintigraphy. Clinical Nuclear Medicine. 28(3). 236–237. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026